Alzheimer's Disease Trial, By Invitation NCT07208734 Sponsor: Xuanwu Hospital, Beijing Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, By Invitation

NCT07208734
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 50 and 90 years, whether currently staying in a hospital or attending as an outpatient.
  • People who have been diagnosed with either mild memory-related cognitive impairment or mild dementia linked to Alzheimer's disease, based on specific 2018 diagnostic guidelines set by leading Alzheimer's research organisations.
  • People whose cognitive testing results fall within a specific range, showing a score of 18 to 26 on the MMSE memory test and a score of 0.5 or 1 on the CDR assessment (confirm with trial site if unsure what these scores mean).
  • People who are able to communicate fluently in Chinese and who are literate.
  • People who are currently taking a memory-related medication such as donepezil or rivastigmine must have been on a stable, unchanged dose for at least six weeks before joining, and must be able to keep that dose unchanged throughout the study.
  • People who are willing and able to provide written consent to participate.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had a stroke in the past that caused clear neurological symptoms and showed related damage on a brain scan.
  • People with moderate to severe white matter changes in the brain, as measured by a specific scoring system (Fazekas score of 3 to 6).
  • People who have any condition that causes disturbances in consciousness or awareness.
  • People with severe difficulties speaking or with physical disabilities that would prevent them from completing cognitive and psychological assessments.
  • People who currently have a diagnosed psychiatric (mental health) disorder.
  • People with a history of alcohol dependence, drug addiction, a serious head injury, epilepsy, brain infection, a condition called normal-pressure hydrocephalus, or other neurological conditions that may affect memory or thinking.
  • People with serious ongoing health conditions in other parts of the body that may affect memory or thinking, such as liver or kidney problems, hormone disorders, or vitamin deficiencies.
  • People whom the trial investigators consider unsuitable for participation for any reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Xuanwu Hospital, Beijing
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
1 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Moca score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov